ECSP993017A - BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES - Google Patents
BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINESInfo
- Publication number
- ECSP993017A ECSP993017A ECSP993017A ECSP993017A EC SP993017 A ECSP993017 A EC SP993017A EC SP993017 A ECSP993017 A EC SP993017A EC SP993017 A ECSP993017 A EC SP993017A
- Authority
- EC
- Ecuador
- Prior art keywords
- general formula
- compounds
- preparation
- valuable
- benzimidazoles
- Prior art date
Links
Abstract
La presente invención se refiere a nuevos bencimidazoles de la fórmula general (gráfico), en la que Ra a Rc, A, Ar y B están definidos como en la reinvindicación 1, sus tautómeros, sus esteroisómeros, sus mezclas, sus profármacos, sus derivados que, en lugar de un grupo carboxi, contienen un grupo cargado negativamente en condiciones fisiológicas, y sus sales, en particular sus sales fisiológicamente compatibles, con ácidos o bases inorgánicos u orgánicos, que presentan valiosas propiedades. Los compuestos de la fórmula general I anterior, en los que Rc representa un grupo ciano, representan valiosos productos intermedios para la preparación de los restantes compuestos de la fórmula general I, y los compuestos de la fórmula general I, en los qur Rc representa uno de los grupos amidino mencionados en la reivindicación 1, presentan valiosas propiedades farmacológicas, en particular un efecto antitrombótico.The present invention relates to new benzimidazoles of the general formula (graph), in which Ra to Rc, A, Ar and B are defined as in claim 1, their tautomers, their stereoisomers, their mixtures, their prodrugs, their derivatives which, instead of a carboxy group, contain a negatively charged group under physiological conditions, and their salts, in particular their physiologically compatible salts, with inorganic or organic acids or bases, which have valuable properties. The compounds of the general formula I above, in which Rc represents a cyano group, represent valuable intermediates for the preparation of the remaining compounds of the general formula I, and the compounds of the general formula I, in which Rc represents one of the amidino groups mentioned in claim 1, have valuable pharmacological properties, in particular an antithrombotic effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993017 ECSP993017A (en) | 1999-06-16 | 1999-06-16 | BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993017 ECSP993017A (en) | 1999-06-16 | 1999-06-16 | BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993017A true ECSP993017A (en) | 1999-11-29 |
Family
ID=42044006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993017 ECSP993017A (en) | 1999-06-16 | 1999-06-16 | BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993017A (en) |
-
1999
- 1999-06-16 EC ECSP993017 patent/ECSP993017A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26903A1 (en) | BICYCLIC HETEROCICLES, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION | |
| UY27078A1 (en) | DERIVATIVES OF QUINAZOLINE, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION | |
| AR025444A1 (en) | DERIVATIVES OF SULFONIL-CARBOXAMIDE, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS | |
| EA200100042A1 (en) | BENZIMIDAZOLES, THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE | |
| UY26066A1 (en) | BICYCLE HETERO CYCLES, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURES FOR THEIR PREPARATION | |
| UY26513A1 (en) | NEW REPLACED PIPERIDINES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION. | |
| ES2161290T3 (en) | DERIVATIVES OF QUINAZOLINA. | |
| BRPI0418031A (en) | phosphonate-substituted kinase inhibitors | |
| CU23105A3 (en) | NOVEDOUS DERIVATIVES OF AMINODICARBOXILIC ACID WITH PHARMACEUTICAL PROPERTIES | |
| GT200100137A (en) | PRO-DRUGS OF 4-PHENYL-PYRIDINE DERIVATIVES. | |
| CO4810373A1 (en) | ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS | |
| AR021844A1 (en) | ARIL-SUBSTITUTED PROPANOLAMINE DERIVATIVES, PROCEDURES FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THEIR USE | |
| ES2192213T3 (en) | ARILALQUIL-DIAZINONAS AS PHOSPHODIESTERASE IV INHIBITORS. | |
| AR004291A1 (en) | NEW AMINO ACID DERIVATIVES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINED IN THESE COMPOUNDS. | |
| UY26086A1 (en) | PROCEDURES AND INTERMEDIATES TO PREPARE ANTI-CANCER COMPOUNDS | |
| SV1999000118A (en) | NEW SUBSTITUTED PIRAZOL DERIVATIVES REF. READ 33188-SV | |
| AR035963A1 (en) | COMPOUNDS DERIVED FROM TRIFLUORMETHYLBENENE USEFUL AS INTERMEDIATES OF THE INHIBITORS OF THE PROTEIN OF TRANSFER OF THE ESTER OF CHOLESTERILE AND PROCEDURES FOR THEIR PREPARATION | |
| MX9303466A (en) | DERIVATIVES OF BIPHENYL, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION. | |
| AR040763A1 (en) | PROFARMACOS OF THE (N-2- PIRIDIL-N-2- HYDROXICARBONIL-ETIL) - AMID OF THE ACID 1- METHYL-2- (4-AMIDINOPHENYLAMINOMETIL) - BENZIMIDAZOL-5-IL-CARBOXILICO, ITS PREPARATION AND ITS USE AS MEDICATIONS | |
| AR027050A1 (en) | BENCIMIDAZOLES, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS | |
| AR021843A1 (en) | DERIVATIVES OF PROPANOLAMINE SUBSTITUTED WITH HETEROCICLES, PROCEDURE FOR THEIR PREPARATION, AND ITS USE. | |
| UY26067A1 (en) | BICYCLE HETERO CYCLES, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURE | |
| MX9302459A (en) | IMINO CYCLE DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION. | |
| UY26273A1 (en) | CARBOXYL ACID AMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| UY27202A1 (en) | AMIDAS OF CARBOXYLIC ACIDS ANTITROMBÓTICAS, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS |